Randomized controlled antiepileptic drug trials miss almost all patients with ongoing seizures
- 1 January 2017
- journal article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 66, 45-48
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical characteristics of patients with epilepsy in a specialist neuropsychiatry serviceEpilepsy & Behavior, 2016
- Managing anti‐epileptic drug treatment in adult patients with intellectual disability: a serious conundrumEuropean Journal of Neurology, 2016
- Recognizing and preventing epilepsy-related mortalityNeurology, 2016
- Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizuresSeizure: European Journal of Epilepsy, 2015
- Adjunctive use of controlled‐release pregabalin in adults with treatment‐resistant partial seizures: A double‐blind, randomized, placebo‐controlled trialEpilepsia, 2014
- First clinical experiences with perampanel—The Kork experience in 74 patientsEpilepsia, 2014
- Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studiesBrain, 2013
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010
- Pharmakotherapie von Epilepsien - Aktuelle Fragen und KontroversenFortschritte der Neurologie · Psychiatrie, 1983